Due for re-check: the scheduled review date of 2026-09-13 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0409-1805-01 · Hydromorphone Hydrochloride Injection · Hospira, Inc., a Pfizer Company
What is the package ndc for 0409-1805-01 · Hydromorphone Hydrochloride Injection · Hospira, Inc., a Pfizer Company?
For 0409-1805-01 · Hydromorphone Hydrochloride Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-1805-01; generic name is Hydromorphone Hydrochloride Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-10.
"initial_posting_date": "11/01/2017", "package_ndc": "0409-1805-01", "generic_name": "Hydromorphone Hydrochloride Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0409-1805-01 verified
- Generic name
- Hydromorphone Hydrochloride Injection verified
- Manufacturer
- Hospira, Inc., a Pfizer Company verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay verified
- Initial posting date
- 11/01/2017 verified
- Last update date
- 08/24/2026 verified
- Days in shortage
- 3226 our reading
- Reason for shortage
- Other verified
- Dosage form
- Injection verified
- Therapeutic category
- Analgesia/Addiction verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/24/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
The same source also states
"initial_posting_date": "11/01/2017", "package_ndc": "0409-1805-01", "generic_name": "Hydromorphone Hydrochloride Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
— api.fda.gov, retrieved 2026-09-15
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000